Effect of interleukin-1-beta on metastasis formation in different tumor systems - PubMed (original) (raw)
. 1991 Jan 16;83(2):119-23.
doi: 10.1093/jnci/83.2.119.
Affiliations
- PMID: 1988686
- DOI: 10.1093/jnci/83.2.119
Effect of interleukin-1-beta on metastasis formation in different tumor systems
M R Bani et al. J Natl Cancer Inst. 1991.
Abstract
Experiments were done to determine the effect of interleukin-1-beta (IL-1 beta) on metastasis formation in different tumor systems. Intravenous administration of 1 microgram of human recombinant IL-1 beta given 1 hour before tumor cell injection augmented lung colony formation (experimental metastases) by the human A375 melanoma variants, the human HT-29M colon carcinoma, the SN12-K1 renal carcinoma in nude mice, the murine B16 melanoma variants, and the murine UV-2237M fibrosarcoma in syngeneic recipients. The same treatment did not induce lung colony formation by a human rectal carcinoma (HCC-P2988) or by a murine reticulum cell sarcoma (M5076), both of which are not metastatic to the lung. Spontaneous metastases were studied in C57BL/6 mice bearing the B16-BL6 melanoma (metastatic to the lung) in their footpad and the M5076 reticulum cell sarcoma (metastatic to the liver) subcutaneously. Daily intraperitoneal treatment with 1 microgram of IL-1 beta increased lung and liver metastases. These findings indicate that treatment of mice with IL-1 beta can increase the number of artificial or spontaneous metastases and that this effect is not limited to a single tumor type or to a specific organ.
Similar articles
- FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F, Farao M, Ciomei M, Pastori A, Mongelli N, Grandi M. Sola F, et al. Invasion Metastasis. 1995;15(5-6):222-31. Invasion Metastasis. 1995. PMID: 8765197 - Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.
Giavazzi R, Garofalo A, Bani MR, Abbate M, Ghezzi P, Boraschi D, Mantovani A, Dejana E. Giavazzi R, et al. Cancer Res. 1990 Aug 1;50(15):4771-5. Cancer Res. 1990. PMID: 2196116 - Syngeneic murine metastasis models: B16 melanoma.
Giavazzi R, Decio A. Giavazzi R, et al. Methods Mol Biol. 2014;1070:131-40. doi: 10.1007/978-1-4614-8244-4_10. Methods Mol Biol. 2014. PMID: 24092437 - Influence of implantation site on formation of metastases.
Meyvisch C. Meyvisch C. Cancer Metastasis Rev. 1983;2(3):295-306. doi: 10.1007/BF00048482. Cancer Metastasis Rev. 1983. PMID: 6367968 Review. - Antiplatelet pyrimido-pyrimidines and metastasis.
Lichtner RB, Hutchinson G, Wedderburn N, Hellmann K. Lichtner RB, et al. Cancer Treat Rev. 1985 Dec;12(4):221-34. doi: 10.1016/0305-7372(85)90006-4. Cancer Treat Rev. 1985. PMID: 3009013 Review.
Cited by
- Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling.
Eyre R, Alférez DG, Santiago-Gómez A, Spence K, McConnell JC, Hart C, Simões BM, Lefley D, Tulotta C, Storer J, Gurney A, Clarke N, Brown M, Howell SJ, Sims AH, Farnie G, Ottewell PD, Clarke RB. Eyre R, et al. Nat Commun. 2019 Nov 1;10(1):5016. doi: 10.1038/s41467-019-12807-0. Nat Commun. 2019. PMID: 31676788 Free PMC article. - Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin.
Mannori G, Santoro D, Carter L, Corless C, Nelson RM, Bevilacqua MP. Mannori G, et al. Am J Pathol. 1997 Jul;151(1):233-43. Am J Pathol. 1997. PMID: 9212748 Free PMC article. - The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.
Volpert OV, Stellmach V, Bouck N. Volpert OV, et al. Breast Cancer Res Treat. 1995;36(2):119-26. doi: 10.1007/BF00666034. Breast Cancer Res Treat. 1995. PMID: 8534861 Review. - Antitumor effects of liposomal IL1 alpha and TNF alpha against the pulmonary metastases of the B16F10 murine melanoma in syngeneic mice.
Saito M, Fan D, Lachman LB. Saito M, et al. Clin Exp Metastasis. 1995 Jul;13(4):249-59. doi: 10.1007/BF00133480. Clin Exp Metastasis. 1995. PMID: 7606887 - Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.
Malik ST, East N, Boraschi D, Balkwill FR. Malik ST, et al. Br J Cancer. 1992 May;65(5):661-6. doi: 10.1038/bjc.1992.141. Br J Cancer. 1992. PMID: 1586593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources